American Public Health Association (APHA)

Special issue of AJPH tackles Health Misinformation on Social Media

Newswise — The volume of anti-vaccine posts that are surfaced by a quick Twitter search can make countering health misinformation seem like an impossible task. However, new research published this month in APHA’s American Journal of Public Health finds a relatively small group of influential, coordinated Twitter accounts can drive a majority of vaccine opposition and misinformation.

The study is part of a special AJPH supplement sponsored by the National Cancer Institute dedicated to “Health Misinformation on Social Media”, which includes a collection of 20 new studies and commentaries, all focused on understanding how and why misinformation spreads and how it can be effectively countered with evidence-based information. Work on the special issue began before the pandemic, but its findings are more relevant than ever as public health workers face an ongoing avalanche of COVID-19 misinformation and prepare to educate their communities on an eventual COVID-19 vaccine.

“The onslaught of misinformation about COVID-19 grabbed news headlines and became a key theme in both public and private discourse during the pandemic, engendering a wider recognition of the urgent need to better understand, and more effectively respond to, health misinformation, including myths and misinformation about cancer,” said the supplement’s Guest Editor Wen-Ying Sylvia Chou, PhD, MPH. “The contributions in this special issue are therefore especially timely.”

For example, the Twitter vaccine study found that while there is a lot of vaccine misinformation on the platform, anti-vaccine conversations seem to be driven by a relatively small number of accounts. To conduct the study, researchers used machine learning to find anti-vaccine Twitter posts and identify the top authors over a period of six months in 2019. They found that just 129 Twitter authors seemed to be driving nearly 60% of all conversation on vaccine opposition. Top opposition authors also appeared to be highly coordinated.

Researchers said the results show that major sources of vaccine misinformation on social media platforms can be found and quantified.

“Individuals and organizations opposed to routine immunization, vaccines, public health policies and government-backed science are readily identifiable,” said study co-author Joe Smyser, PhD, CEO of the Public Good Projects. “They reach millions of people with misinformation and disinformation. What we do about this as a society remains an open question, but we can't claim that we don't know the who, what, when, where and why of this opposition movement.”

Other studies and analyses in the special issue include research on breast cancer misinformation on Pinterest, the framing of vaccine refusal as a civil right on Facebook, and how GoFundMe can spread misinformation about cancer treatments. Editorials in the special issue explore strategies for countering health misinformation and highlight the need for more research on how it spreads, why it works and how to crowd it out.

“It is time to boldly explore innovative, adaptive and alternative approaches to both disseminating evidence-based information and mitigating the impact of misinformation,” writes Chou in an editorial. “With COVID-19 continuing to cause global suffering and disruptions, understanding and combatting health misinformation is one of the most urgent public health priorities of our time.”

The special AJPH supplement, “Health Misinformation on Social Media,” is available online. To request a full copy of a study or for information on scheduling interviews, contact APHA Media Relations.

 

The issue was funded in whole or in part with federal funds from the National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, MD, under Contract No. HHSN261201700004I. The opinions expressed by the authors are their own, and this material should not be interpreted as representing the official viewpoint of the US Department of Health and Human Services, the National Institutes of Health, or the National Cancer Institute.

 

                                                            ###

 

The American Journal of Public Health is the monthly journal of the American Public Health Association. APHA champions the health of all people and all communities. We are the only organization that combines a nearly 150-year perspective, a broad-based member community and the ability to influence policy to improve the public's health. Learn more at www.apha.org.

MEDIA CONTACT
Register for reporter access to contact details
CITATIONS

APHA’s American Journal of Public Health




Filters close

Showing results

110 of 4156
Newswise: Stimulus Relief Funds Increase Social Distancing to Stop Spread of COVID-19
23-Nov-2020 5:20 PM EST
Stimulus Relief Funds Increase Social Distancing to Stop Spread of COVID-19
University of California San Diego

As case rates of COVID-19 reach new heights across the nation, many states and cities are tightening stay-at-home restrictions to stop the spread. New research suggests that that those suffering from economic hardships are less likely comply with new stay-at-home orders; however these same U.S. residents would be more likely to adhere to the new public health guidelines if their households received stimulus funds.

access_time Embargo lifts in 2 days
Embargo will expire: 1-Dec-2020 9:15 AM EST Released to reporters: 30-Nov-2020 2:30 PM EST

A reporter's PressPass is required to access this story until the embargo expires on 1-Dec-2020 9:15 AM EST The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Newswise:Video Embedded covid-19-update-surge-preparedness-vaccine-distribution
VIDEO
Released: 30-Nov-2020 2:20 PM EST
COVID-19 Update: Surge Preparedness, Vaccine Distribution
Cedars-Sinai

With the novel coronavirus spreading across the U.S. at a record pace, Cedars-Sinai has been seeing an increase in COVID-19 patients at its hospitals and through its network of physicians. But the health system's leaders say Cedars-Sinai is prepared.

Released: 30-Nov-2020 1:20 PM EST
Rethink COVID-19 infection control to keep primary schools open this winter, governments urged
BMJ

An urgent rethink of infection control policies to keep COVID-19 infection at bay in schools is needed if primary schools are to be kept open this winter, and the knock-on effects on their families avoided, argue children's infectious disease specialists in a viewpoint, published online in the Archives of Disease in Childhood.

Newswise: Hackensack University Medical Center Urologists Continue to Provide State-of-the-Art Care During COVID-19
Released: 30-Nov-2020 12:45 PM EST
Hackensack University Medical Center Urologists Continue to Provide State-of-the-Art Care During COVID-19
Hackensack Meridian Health

Don’t Delay Your Care – Our dnhanced pandemic safety precautions prioritize patient health and allow providers to deliver outstanding in-office, telehealth and surgical care

Released: 30-Nov-2020 12:10 PM EST
Struggles of care home staff during COVID-19 first wave revealed in Whatsapp messages
University of Leeds

Analysis of social media messages between care home staff on the coronavirus front line reveal their growing concerns over how to manage in the face of the virus.

Released: 30-Nov-2020 11:30 AM EST
More than one-third of children with COVID-19 show no symptoms: study
University of Alberta Faculty of Medicine & Dentistry

More than one-third of kids who have COVID-19 are asymptomatic, according to a University of Alberta study that suggests youngsters diagnosed with the disease may represent just a fraction of those infected.

Newswise: Promising lab results in quest to find naturally occurring anti-COVID therapies
24-Nov-2020 5:35 PM EST
Promising lab results in quest to find naturally occurring anti-COVID therapies
University of Alabama Huntsville

So far, 35 of 125 naturally occurring compounds identified computationally at The University of Alabama in Huntsville (UAH) to have potential against COVID-19 have shown efficacy in ongoing first-batch testing at the University of Tennessee Health Science Center’s Regional Biocontainment Laboratory (UTHSC RBL) that’s the next step in the process to becoming a drug.

Released: 30-Nov-2020 9:45 AM EST
Rutgers Leading Coronavirus Therapeutic Clinical Trial
Rutgers University-New Brunswick

Rutgers is leading a clinical trial assessing the efficacy of a three-drug combination in treating people infected with SARS-CoV-2 and asymptomatic or mildly symptomatic.


Showing results

110 of 4156

close
2.10824